Works matching IS 22965270 AND DT 2016 AND VI 39 AND IP 5
Results: 24
Meetings and Conferences.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 315, doi. 10.1159/000446205
- Publication type:
- Article
Tagrisso® im deutschen Markt verfügbar: Resistenz überwinden mit dem ersten EGFR-TKI der 3. Generation.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 314
- By:
- Publication type:
- Article
Hoher Stellenwert der zielgerichteten Behandlung mit Avastin® im klinischen Alltag.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 314
- By:
- Publication type:
- Article
Von Novartis Oncology initiierte App zur Diagnose und Behandlung des Nierenzellkarzinoms für den Praxisalltag jetzt verfügbar.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 312
- By:
- Publication type:
- Article
Tasigna®: Verbesserte Behandlungsperspektiven bei chronischer myeloischer Leukämie.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 312
- By:
- Publication type:
- Article
Zulassungserweiterung um die Indikation vorbehandeltes fortgeschrittenes nichtkleinzelliges Bronchialkarzinom (NSCLC) bei Patienten mit PD-L1-positiven Tumoren angestrebt.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 311
- By:
- Publication type:
- Article
Azacitidin verbessert Gesamtüberleben bei älteren Patienten mit mehr als 30% Knochenmarkblasten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 311
- By:
- Publication type:
- Article
Deutscher Krebskongress 2016 - Hoher Stellenwert der neuen Dreierkombinationen beim rezidivierten multiplen Myelom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 310
- Publication type:
- Article
Molekulare Gendiagnostik mit NEO-Technologie ermöglicht gezieltere Therapie beim NSCLC.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 310
- By:
- Publication type:
- Article
Hohe Ansprechraten mit dem selektiven BCL2-Inhibitor Venetoclax.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 310
- By:
- Publication type:
- Article
Kasuistik: Zweitlinientherapie des fortgeschrittenen Magenkarzinoms mit Ramucirumab.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 309
- Publication type:
- Article
Ein wichtiger Fortschritt in der palliativen Behandlung des fortgeschrittenen Magenkarzinoms.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 309
- Publication type:
- Article
Ramucirumab: Wichtige Erweiterung in der Palliativtherapie.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 308
- By:
- Publication type:
- Article
Patienten können von Ipilimumab nach PD-1-Hemmung profitieren.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 307
- By:
- Publication type:
- Article
Monatsthema im Mai: Leukämien: Stammzellen spenden - Leben retten.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 305
- Publication type:
- Article
Leukemia Clinical Research Award der DGHO.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 304
- By:
- Publication type:
- Article
Psychologische Beratung für krebskranke Frauen in türkischer Sprache.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 303
- By:
- Publication type:
- Article
Targeted Therapy in HER2-Positive Breast Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 295, doi. 10.1159/000446038
- By:
- Publication type:
- Article
Advances in Image-Guided Radiation Therapy for Primary Cardiac Angiosarcoma: The Role of PET-CT and MRI.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 290, doi. 10.1159/000445864
- By:
- Publication type:
- Article
Diagnostic Impacts of Serum CA-125 Levels, Pap Smear Evaluation, and Endometrial Sampling in Women with Endometrial Clear Cell Carcinoma.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 283, doi. 10.1159/000445860
- By:
- Publication type:
- Article
Internet Information for Patients on Cancer Diets - an Analysis of German Websites.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 273, doi. 10.1159/000445861
- By:
- Publication type:
- Article
C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 266, doi. 10.1159/000446098
- By:
- Publication type:
- Article
Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 260, doi. 10.1159/000446008
- By:
- Publication type:
- Article
Challenging Results Make Us Think.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 5, p. 258, doi. 10.1159/000446163
- By:
- Publication type:
- Article